DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Duoneb (Albuterol Sulfate / Ipratropium Bromide) - Published Studies

 
 



Duoneb Related Published Studies

Well-designed clinical trials related to Duoneb (Albuterol / Ipratropium)

Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. [2004.10.23]

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD. [2004]

An evaluation of nebulized levalbuterol in stable COPD. [2003.09]

Addition of ipratropium to nebulized albuterol in children with acute asthma presenting to a pediatric office. [2003.03]

Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. [2001.12]

Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children. [2001.12]

Lower arrythmogenic risk of low dose albuterol plus ipratropium. [2001.10]

Ipratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma. [2001.01]

First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. [2000.06]

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. [1999.05]

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. [1999.04]

Effect of continuously nebulized ipratropium bromide plus albuterol on emergency department length of stay and hospital admission rates in patients with acute bronchospasm. A randomized, controlled trial. [1999.04]

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. [1999.03]

For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. [1999.01.25]

Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. [1998.02]

Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. [1998]

Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. [1997.06]

A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. [1996.09]

Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. [1995.04]

Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. [1992.12]

Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study. [1991.10.21]

Additive effect of albuterol and ipratropium bromide in the treatment of bronchospasm in children. [1990.10]

A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. [1989.03]

Well-designed clinical trials possibly related to Duoneb (Albuterol / Ipratropium)

The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. [2005.07]

Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. [2005.06.01]

Effects of two nebulization regimens on heart rate variability during acute asthma exacerbations in children. [2005.05]

Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD. [2005.04]

Bronchodilators in bronchoscopy-induced airflow limitation in allergen-sensitized cats. [2005.03]

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. [2005.01]

Comparison of the effects of ipratropium bromide and salbutamol on autonomic heart rate control. [2004.11]

Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. [2004.06]

The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry. [2004.04]

Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. [2004.02]

Triple inhaled drug protocol for the treatment of acute severe asthma. [2003.06]

A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. [2003.06]

Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma. [2003.04]

A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. [2003.04]

Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial. [2003.04]

Meaningful effect size and patterns of response of the transition dyspnea index. [2003.03]

Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. [2003.03]

Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). [2003]

The effect of heliox-driven bronchodilator aerosol therapy on pulmonary function tests in patients with asthma. [2002.10]

Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma. [2002.08]

An evaluation of salmeterol in the treatment of chronic obstructive pulmonary diseases. [2002.07]

What is the optimal treatment strategy for chronic obstructive pulmonary disease exacerbations? [2002.05]

Use of a mucus clearance device enhances the bronchodilator response in patients with stable COPD. [2002.03]

[Benefits of ipratropium bromide in the management of asthmatic crises in the emergency department] [2002.02]

Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department. [2002.02]

Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen. [2002.02]

Heliox for treatment of exacerbations of chronic obstructive pulmonary disease. [2002]

[RC-Cornet(R) improves the bronchodilating effect of Ipratropiumbromide (Atrovent(R)) inhalation in COPD-patients] [2001.10]

Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. [2001.09]

Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. [2001.07]

Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. [2001.06]

Bronchodilatory effects of salbutamol, ipratropium bromide, and their combination: double-blind, placebo-controlled crossover study in cystic fibrosis. [2001.06]

Efficacy of IV theophylline in children with severe status asthmaticus. [2001.05]

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. [2001.05]

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. [2001.04]

The role of domiciliary nebulizers in managing patients with severe COPD. [2001.04]

Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease. [2001.01]

[Efficacy of early administration of nebulized ipratropium bromide in children with asthmatic crisis] [2000.09]

Randomized trial of the use of heliox as a driving gas for updraft nebulization of bronchodilators in the emergent treatment of acute exacerbations of chronic obstructive pulmonary disease. [2000.09]

Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. [2000.05]

Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. [2000.03]

Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department? [2000.02]

[Degree and duration of bronchodilatation with an agonist beta 2 administered alone versus an agonist beta 2 administered with ipratropium bromide in children with acute asthma] [2000.01]

An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. [1999.11]

A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. [1999.10]

Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: A randomized controlled study. [1999.05]

Efficacy of salmeterol xinafoate in the treatment of COPD. [1999.04]

Ipratropium bromide added to asthma treatment in the pediatric emergency department. [1999.04]

Randomised controlled trial of aminophylline for severe acute asthma. [1998.11]

Effect of nebulized ipratropium on the hospitalization rates of children with asthma. [1998.10.08]

Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma. [1998.10]

Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease. [1998.09]

The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. [1998.08]

How long should Atrovent be given in acute asthma? [1998.05]

Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients. [1998.02]

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease. [1998.02]

Is it useful to add an anticholinergic treatment to beta 2-adrenergic medication in acute asthma attack? [1998.01]

Efficacy of bronchodilators in the treatment of bronchiolitis. [1997.08]

Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma. [1997.08]

Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. [1997.07]

Hospitalization patterns in severe acute asthma in children. [1997.03]

Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. [1997.02]

The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. [1997.02]

Efficacy of nebulized ipratropium in severely asthmatic children. [1997.02]

Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. [1996.11]

Nebulized flunisolide in infants and young children with asthma: a pilot study. [1996.05]

Effects of theophylline and ipratropium on cognition in elderly patients with chronic obstructive pulmonary disease. [1996.04]

Time course of methacholine induced bronchoconstriction during drugs and spontaneous resolution. [1996.03]

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease. [1996.01.29]

Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease. [1996.01.29]

A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease. [1995.12]

Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD? [1995.09]

Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. [1995.08]

The influence of an inhaled steroid on quality of life in patients with asthma or COPD. [1995.05]

Continuous and on demand use of bronchodilators in patients with non-steroid dependent asthma and chronic bronchitis: four-year follow-up randomized controlled study. [1995.05]

The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. [1995.04]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017